Page last updated: 2024-08-24

1,2-distearoyllecithin and Leishmaniasis, Visceral

1,2-distearoyllecithin has been researched along with Leishmaniasis, Visceral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, N; Maji, M; Mazumder, S1
Ali, N; Bhowmick, S; Ravindran, R1

Other Studies

2 other study(ies) available for 1,2-distearoyllecithin and Leishmaniasis, Visceral

ArticleYear
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.
    PLoS neglected tropical diseases, 2011, Volume: 5, Issue:12

    Topics: Adjuvants, Immunologic; Animals; Cord Factors; Cytokines; Disease Models, Animal; Female; Humans; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Th1 Cells; Vaccination; Vaccines, Synthetic

2011
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
    Infection and immunity, 2008, Volume: 76, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Immunologic; Immunoglobulin G; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Liposomes; Liver; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Spleen; T-Lymphocyte Subsets; Th1 Cells; Time Factors

2008